Presence of Microvascular Dysfunction and CHA2DS2-VASc Score in Patients with ST-Segment Myocardial Infarction after

Ragab A Mahfouz1, Marwa M Gad1, Mohamed Arab1

  • 1Cardiology Department, Zagazig University Hospital, Zagazig, Egypt.

Insights

The CHA2DS2-VASc score can predict microvascular dysfunction (MVD) after ST-segment elevation myocardial infarction (STEMI) treatment. A higher score indicates increased MVD risk following primary percutaneous intervention (PPCI).

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Medicine

Background:

  • Microvascular dysfunction (MVD) is a complication after primary percutaneous intervention (PPCI) for ST-segment elevation myocardial infarction (STEMI).
  • Assessing MVD risk is crucial for optimizing patient outcomes.
  • The CHA2DS2-VASc score is a validated risk stratification tool in cardiovascular disease.

Purpose of the Study:

  • To investigate the relationship between the CHA2DS2-VASc score and microvascular resistance (IMR) in STEMI patients post-PPCI.
  • To determine if the CHA2DS2-VASc score can predict MVD, assessed by IMR, immediately after PPCI.

Main Methods:

  • A study of 115 STEMI patients undergoing successful PPCI.
  • Assessment of microvascular resistance (IMR) using the index of microvascular resistance.
  • Correlation analysis between CHA2DS2-VASc score, IMR, and echocardiographic parameters.

Main Results:

  • Patients with higher IMR (≥40 U) exhibited significantly higher CHA2DS2-VASc scores (p < 0.001).
  • CHA2DS2-VASc score strongly correlated with increased IMR and indicators of cardiac dysfunction.
  • Multivariate analysis identified CHA2DS2-VASc score ≥4 as optimal for predicting MVD (IMR ≥40) in STEMI patients.

Conclusions:

  • Increased CHA2DS2-VASc score is associated with a higher incidence of MVD (elevated IMR) after PPCI in STEMI.
  • The CHA2DS2-VASc score may serve as a practical, cost-effective tool for predicting MVD risk in these patients.
  • Lower systolic blood pressure and stent diameter also correlate with MVD post-PPCI.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
38
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
105
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
42
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
57
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
51
Assessment of the Cardiovascular System III: Palpation01:27

Assessment of the Cardiovascular System III: Palpation

Palpation involves feeling the body to evaluate texture, size, consistency, and tenderness for assessing cardiovascular health. The following steps are organized in a head-to-toe order:
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
541